Vanguard Global Advisers
ZURA icon

Vanguard Global Advisers’s Zura Bio ZURA Stock Holding History

Vanguard Global Advisers’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.2K Hold
16,821
– – ﹤0.01% 2784
2026
Q1 		$100K Buy
+16,821
New +$102K ﹤0.01% 2727

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Global Advisers's ZURA Position: Q2 2026 in Review

Vanguard Global Advisers held its Zura Bio (ZURA) position steady in Q2 2026 at 16,821 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2784.

Vanguard Global Advisers first reported a position in ZURA in Q1 2026 and has held it in 2 quarters since. The position peaked at $100K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Vanguard Global Advisers held 16,821 shares of Zura Bio worth $99.2K as of Q2 2026.
  • Vanguard Global Advisers left its Zura Bio share count unchanged in Q2 2026.
  • Zura Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2784 holding.
  • Vanguard Global Advisers first reported a position in Zura Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Zura Bio position peaked at $100K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.